이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Eden Research 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Sean Smith

최고 경영자

UK£577.0k

총 보상

CEO 급여 비율	50.1%
CEO 임기	9.8yrs
CEO 소유권	0.2%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	9.2yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Sean Smith 의 보수는 Eden Research 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Dec 31 2023	UK£577k	UK£289k	-UK£6m
Sep 30 2023	n/a	n/a	-UK£7m
Jun 30 2023	n/a	n/a	-UK£7m
Mar 31 2023	n/a	n/a	-UK£5m
Dec 31 2022	UK£360k	UK£273k	-UK£2m
Sep 30 2022	n/a	n/a	-UK£2m
Jun 30 2022	n/a	n/a	-UK£2m
Mar 31 2022	n/a	n/a	-UK£2m
Dec 31 2021	UK£739k	UK£253k	-UK£3m
Sep 30 2021	n/a	n/a	-UK£3m
Jun 30 2021	n/a	n/a	-UK£3m
Mar 31 2021	n/a	n/a	-UK£3m
Dec 31 2020	UK£421k	UK£235k	-UK£2m
Sep 30 2020	n/a	n/a	-UK£2m
Jun 30 2020	n/a	n/a	-UK£2m
Mar 31 2020	n/a	n/a	-UK£1m
Dec 31 2019	UK£349k	UK£212k	-UK£1m
Sep 30 2019	n/a	n/a	-UK£594k
Jun 30 2019	n/a	n/a	-UK£44k
Mar 31 2019	n/a	n/a	-UK£189k
Dec 31 2018	UK£353k	UK£190k	-UK£335k
Sep 30 2018	n/a	n/a	-UK£1m
Jun 30 2018	n/a	n/a	-UK£2m
Mar 31 2018	n/a	n/a	-UK£1m
Dec 31 2017	UK£258k	UK£147k	-UK£639k

보상 대 시장: Sean 의 총 보상 ($USD 733.88K )은 German 시장( $USD 434.78K ).

보상과 수익: 회사가 수익성이 없는 동안 Sean 의 보상이 증가했습니다.

CEO

Sean Smith (57 yo)

9.8yrs

테뉴어

UK£577,046

보상

Mr. Sean Michael Smith has been the Chief Executive Officer of Eden Research PLC since September 1, 2014. Mr. Smith served as the Head of Europe and Innovation Advisor at Intellectual Ventures - Invention...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Sean Smith	CEO & Executive Director	9.8yrs	UK£577.05k	0.22% £ 61.6k
Alexander Abrey	CFO, Secretary & Executive Director	16.8yrs	UK£433.42k	0.33% £ 91.6k
Gary Ostroff	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Robin James Cridland	Independent Non-Executive Director	9.2yrs	UK£40.00k	0.14% £ 38.5k
Lykele van der Broek	Independent Non-Executive Chairman	6.8yrs	UK£45.00k	0.30% £ 83.7k
Richard Smart	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Paul Williams	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Chung-Jan Chang	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Derek McAllan	Non-Executive Director	less than a year	데이터 없음	0.061% £ 16.7k

9.2yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: 9T7 의 이사회는 경험(평균 재직 기간 9.1 년)으로 간주됩니다.

Eden Research 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Eden Research plc Announces Appointment of Daniel Mulas García as Global Product and Marketing Lead

Eden Research plc Appoints Humair Tariq as New Global Commercial Lead

Eden Research plc Announces Appointment of Derek Mcallan as Non-Executive Director and as Chairman of the Audit Committee Following the Company's 2024 AGM

Insufficient new directors

Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive Director

Eden Research plc, Annual General Meeting, Jun 29, 2023

Recent updates

Eden Research plc Announces Appointment of Daniel Mulas García as Global Product and Marketing Lead

Eden Research plc Announces Biofungicide Label Extension in Spain

Eden Research plc Appoints Humair Tariq as New Global Commercial Lead

Full year 2023 earnings released: UK£0.015 loss per share (vs UK£0.006 loss in FY 2022)

Eden Research plc to Report Fiscal Year 2023 Results on May 07, 2024

Eden Research plc Announces Appointment of Derek Mcallan as Non-Executive Director and as Chairman of the Audit Committee Following the Company's 2024 AGM

New major risk - Revenue and earnings growth

Full year 2023 earnings released: UK£0.015 loss per share (vs UK£0.006 loss in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive Director

Eden Research plc Provides Revenue Guidance for the Full Year of 2023

First half 2023 earnings released: UK£0.015 loss per share (vs UK£0.003 loss in 1H 2022)

Eden Research plc to Report First Half, 2023 Results on Sep 29, 2023

New major risk - Revenue and earnings growth

New minor risk - Shareholder dilution

Eden Research plc Announces Regulatory Application for Authorised Use of Ecovelex™ in the United Kingdom

Eden Research plc, Annual General Meeting, Jun 29, 2023

Full year 2022 earnings released: UK£0.006 loss per share (vs UK£0.007 loss in FY 2021)

Eden Research plc to Report Fiscal Year 2022 Results on May 05, 2023

Eden Research plc Announces First Mevalone Authorisation for Domestic Use

Eden Research plc Provides Revenue Guidance for the Full Year of 2022

Less than half of directors are independent

First half 2022 earnings released: EPS: UK£0 (vs UK£0.004 loss in 1H 2021)

Eden Research plc Grants US EPA Regulatory Approval

Eden Research plc Appoints Richard Horsman as Non-Executive Director, with effect from 1 September 2022

Eden Research plc, Annual General Meeting, Jun 29, 2022

Full year 2021 earnings released: UK£0.007 loss per share (vs UK£0.007 loss in FY 2020)

Eden Research plc Announces Progress Towards EPA Approval and Further Authorisation in Italy

Insufficient new directors

First half 2021 earnings released: UK£0.004 loss per share (vs UK£0.004 loss in 1H 2020)

Eden Research plc Announces New Label Extension for Biofungicide in Portugal

Full year 2020 earnings released: UK£0.007 loss per share (vs UK£0.005 loss in FY 2019)

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령